Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.1100 (2.01%) ($38.1100 - $38.1100) on Tue. May. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 29 | Latest Price | $38.1100(2.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.5% a day on average for past five trading days. | Weekly Trend | HALO declines -5.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWO(44%) IWM(43%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.035% in a week (0% probabilities). VIXM(-22%) UUP(-10%) VXX(-7%) TBT(-3%) GLD(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $31.18(-18.18%) | Resistance Level | $41.38 | 5 Day Moving Average | $39.23(-2.85%) | 10 Day Moving Average | $40.07(-4.89%) | 20 Day Moving Average | $41.38(-7.9%) | To recent high | -14.5% | To recent low | 16.4% | Market Cap | $5.209b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |